Curative Biotechnology Inc (CUBT)

[lizardlover]

This is not about their pipeline anymore...

I have watched several interviews with the CEO where he stated that they had supply chain issues at that time and that was the reason they couldn't start trials. Yet other Bios continued with their trials w/o issues....

I think the CEO was lying and it is not a supply chain issue... I think they have problems with their drug formulations.

By the time they progress on their portfolio this will be diluted to death and your shares will become worthless.

Those who are gonna benefit are the people that buy the bottom after the current holders are wiped out (somewhere in the trips). And believe you me, all the current holders are getting wiped out, no question about it.

But to answer your question - the eyedrops are promising yes, but that is irrelevant since like I said, by the time that drug is out, assuming if they can actually get it out and get the right formulation etc. (which I have my doubts about ) your shares will have no worth...

Unless, like I stated before, they find a cure for cancer before the R/S and this flies.